References
- Inzucchi SE Bergenstal RM Buse JB Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetologia 2015 58 429 442 25583541
- National Institute for Health and Care Excellence Guidance [webpage on the Internet] Type 2 diabetes: the management of type 2 diabetes Available from: https://www.nice.org.uk/guidance/ng28 Accessed August 18, 2016
- Stark Casagrande S Fradkin JE Saydah SH Rust KF Cowie CC The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010 Diabetes Care 2013 36 2271 2279 23418368
- Ali MK McKeever Bullard K Imperatore G Barker L Gregg EW Centers for Disease Control and Prevention (CDC) Characteristics associated with poor glycemic control among adults with self-reported diagnosed diabetes – National Health and Nutrition Examination Survey, United States, 2007–2010 MMWR Morb Mortal Wkly Rep 2012 61 suppl 32 37
- Health and Social Care Information Centre National Diabetes Audit 2012–2013. Report 1: Care Processes and Treatment Targets 2014 Available from: http://www.hscic.gov.uk/catalogue/PUB14970/nati-diab-audi-12-13-care-proc-rep.pdf Accessed August 18, 2016
- Anderson P Benford M Harris N Karavali M Piercy J Real-world physician and patient behaviour across countries: disease-specific programmes – a means to understand Curr Med Res Opin 2008 24 3063 3072 18826746
- US Department of Health and Human Services Summary of the HIPAA Privacy Rule 2003 Available from: http://www.hhs.gov/sites/default/files/privacysummary.pdf Accessed August 18, 2016
- EphMRA Code of Conduct [webpage on the Internet] Updated January 2016. Available from: http://www.ephmra.org/code-of-conduct/2/A-Purpose-Scope-and-Sources Accessed August 18, 2016
- Health Information Technology Health Information Technology Act Available from: https://www.healthit.gov/sites/default/files/hitech_act_excerpt_from_arra_with_index.pdf Accessed August 18, 2016
- Silvey M Higgins V Leith A Benford M Graham A Piercy J International differences in the role of payer and administrative controls in prescribing decisions in type 2 diabetes mellitus (T2DM) Value Health 2016 19 A209
- U.S. Food & Drug Administration [webpage on the Internet] FDA Adds Boxed Warning for Heart-related Risks to Anti-Diabetes Drug Avandia Agency says drug to remain on market, while safety assessment continues 2007 Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109026.htm Accessed September 13, 2016
- Sharma M Nazareth I Petersen I Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study BMJ Open 2016 6 1 e010210 Erratum BMJ Open 2016 6 e010210corr1
- Liu SC Tu YK Chien MN Chien KL Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis Diabetes Obes Metab 2012 14 9 810 820 22486990
- Saunders C Byrne CD Guthrie B Scottish Diabetes Research Network Epidemiology Group External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants? Diabet Med 2013 30 3 300 308 23075287
- Hubbard TE Paradis R Real-World Evidence: A New Era for Health Care Innovation The Network for Excellence in Health Innovation 2015 Available from: http://www.nehi.net/writable/publication_files/file/rwe_issue_brief_final.pdf Accessed August 18, 2016